Company: RPTX
Filing Date: 2025-12-03
Form Type: PREM14A
Source: 0001193125-25-306948
Chunk: 404

Company: Repare Therapeutics Inc.
Filing Date: 2025-12-03
Form: PREM14A
Chunk 404
---
 if thought advisable, to pass, with or without variation, a special #P3# resolution pursuant to Section 308 of the QBCA to approve the voluntary liquidation (the “Liquidation”) and dissolution of the Company in the event the Arrangement is terminated (the “Liquidation Resolution”).4. In the event that the Arrangement Resolution is not approved or the Arrangement is otherwise terminated, to consider, and if thought advisable, to pass, with or without variation, a sepcial #P4# resolution pursuant to Section 325 of the QBCA to approve the appointment of KPMG LLP(‘KPMG”) or, in the alternative, another liquidator of nationally recognized experience, as the liquidator of the Company (the “Liquidator”) with authorization for the board of directors of the Company (the “Board”) to set the remuneration of the liquidator (the Liquidator Resolution”). NOTE: To transact such further or other business that may properly come before the Special Meeting or any adjournment or postponement thereof. BOARD OF DIRECTORSYOUR VOTE RECOMMENDS FOR AGAINST ABSTAINFOR#P1# #P1#FORFORFORYou must pre-registerto attend the meeting online and/or participate at www.proxydocs.com/RPTX.Authorized Signatures—Must be completed for your instructions to be executed. Please sign exactly as your name(s) appears on your account. If held in joint tenancy, all persons should sign. Trustees, administrators, etc., should include title and authority. Corporations should provide full name of corporation and title of authorized officer signing the Proxy/Vote Form. Signature (and Title if applicable) Date Signature (if held jointly) Date